文献速递脑血管病

绝经与女性卒中风险的意义

Menopause and Its Implications for Stroke in Women.
PubMed 文献 · Stroke · 2026-06-24

本文综述绝经及其特征与女性卒中风险的关联。绝经类型、时机、内源性激素及血管舒缩症状和睡眠问题均影响卒中风险;绝经激素治疗的风险因制剂、给药途径及使用者年龄和健康状况而异。

要点

  • 绝经类型、时机及内源性激素谱与女性卒中风险相关。
  • 血管舒缩症状和睡眠问题等绝经症状亦与卒中风险相关。
  • 经皮绝经激素治疗用于较年轻中年女性可能具有更有利的风险特征。

核心结论

  • 绝经及其特征与女性卒中风险相关,临床决策需综合考虑绝经类型、时机、症状及激素治疗特征。

研究设计与样本

  • 综述总结了绝经与卒中关联的数据,并提出临床决策建议和未来研究方向。

主要发现

  • 绝经类型和时机、内源性激素谱以及血管舒缩症状和睡眠问题与女性卒中风险相关。
  • 绝经激素治疗的卒中风险因制剂、给药途径及使用者年龄和健康状况而异。
  • 经皮绝经激素治疗用于较年轻中年女性显示出更有利的特征。

临床怎么用

  • 临床决策应综合考虑绝经特征、症状及激素治疗的制剂、途径和个体因素。

局限性

  • 本文为综述,指出知识空白并强调未来研究方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Stroke is the third leading cause of death in women and a major driver of disability. Menopause is a universal transition for midlife women, which is accompanied by menstrual cycle changes, hormonal fluctuations, and, for many women, the occurrence of menopausal symptoms. An accumulating body of research underscores the importance of menopause and its features to stroke risk in women, including the type and timing of menopause, endogenous hormone profiles, and menopausal symptoms, including vasomotor symptoms and sleep problems. In addition, menopausal hormone therapy, a leading approach to managing menopausal symptoms, has implications for stroke risk, which varies depending on the menopausal hormone therapy formulation, route of delivery, and the age and health of the recipient, with transdermal menopausal hormone therapy formulations administered to younger midlife women showing a more favorable profile. This review summarizes the data linking menopause and stroke, and offers suggestions to inform clinical decision-making. Knowledge gaps and directions for future research are highlighted.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Thurston RC, Spicuzza JM, Schroeder RA, et al. Menopause and Its Implications for Stroke in Women. Stroke. 2026. PMID: 42339545. doi:10.1161/STROKEAHA.126.052889

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。